hr

Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Top

Chair(s)

  • Pierluigi Toniutto

    Assistant Professor of Medicine, Director of Hepatology and Liver Transplant Unit, University of Udine, Udine, Italy.

Speakers

  • Vincenzo Mazzaferro

    Full Professor of Surgery at the Department of Oncology of the University of Milan and Director of the Gastro-Intestinal Surgery and Liver Transplantation Unit at the Istituto Nazionale Tumori (National Cancer Institute), Milan, Italy.

    Topic: Liver surgery: any chance to surpass the current limitations in treating hepatocellular carcinoma?

  • Jessica Zucman-Rossi

    Professor of Oncology in University Paris Descartes and director of the Inserm Unit "Functional Genomic of Solid Tumors", Paris, France.

    Topic: Biochemical, genetic, and histological markers to select patients with hepatocellular carcinoma for
    liver transplantation

  • Myron E. Schwartz

    The Henry Kaufmann Professor of Surgery, and Director of Liver Surgery, Recanati/Miller Transplantation Institute, The Mount Sinai Medical Center, New York, USA.

    Topic: The changing face of hepatocellular carcinoma: Implications for surgical management

  • Patrizia Burra

    Professor of Gastroenterology and Head of the Multivisceral Transplant Unit, University Hospital Padua, Italy.

    Topic: The changing epidemiology and risk factors for hepatocellular carcinoma

  • Umberto Cillo

    Professor of General Surgery from the University of Padova, Director at the University of Padova, Padua, Italy.

    Topic: New horizons of downstaging treatments before liver transplant

  • Jan Lerut

    Professor Emeritus of Surgery, Director of the Starzl Abdominal Transplant Unit, University Hospitals Saint Luc and UCL Transplant Centre in Brussels, and Past President of European Society of Organ Transplantation and International Society of Liver Transplantation, Brussels, Belgium.

    Topic: Liver transplantation and hepatocellular carcinoma: from extended to advanced criteria

  • Nobuhisa Akamatsu

    Lecturer of Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

    Topic: The management of recipient after liver transplantation for hepatocellular carcinoma in the era of expanded criteria

Programme

      Time (Rome)
      Speakers
      Topics
      14:00 - 14:10
      Pierluigi Toniutto
      Welcome Speech
      14:10 - 14:30
      Patrizia Burra
      The changing epidemiology and risk factors for hepatocellular carcinoma
      14:30 - 14:50
      Myron E. Schwartz
      The changing face of hepatocellular carcinoma: implications for surgical management
      14:50 - 15:10
      Vincenzo Mazzaferro
      Liver surgery: any chance to surpass the current limitations in treating hepatocellular carcinoma?
      15:10 - 15:25
      Pierluigi Toniutto
      Discussion (Q&A)
      15:25 - 15:45
      Jessica Zucman-Rossi
      Biochemical, genetic, and histological markers to select patients with hepatocellular carcinoma for liver transplantation
      15:45 - 16:05
      Umberto Cillo
      New horizons of downstaging treatments before liver transplant
      16:05 - 16:25
      Jan Lerut
      Liver transplantation and hepatocellular carcinoma: from extended to advanced criteria
      16:25 - 16:45
      Nobuhisa Akamatsu
      The management of recipient after liver transplantation for hepatocellular carcinoma in the era of expanded criteria
      16:45 - 17:00
      Pierluigi Toniutto
      Discussion (Q&A)
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties